India’s Biocon Breaks Into Global Top 10 Biotech List
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Indian biotech firm Biocon has emerged as the seventh largest employer among the top global biotech companies, according to a survey released by Med Ad News
You may also be interested in...
India’s Biocon Moves Forward With Oral Insulin After Encouraging Phase II Results
MUMBAI - In what is seen as a significant development for the company, Indian biotechnology firm Biocon presented encouraging Phase II data on its experimental oral insulin drug coded IN-105 at the European Association for the Study of Diabetes meeting being held at Rome
India’s Biocon Buys 70 Percent Stake In German Drug Firm AxiCorp GmbH
BANGALORE, India - India's Biocon Ltd. said it paid €30 million ($43.5 million) to buy a 70 percent stake in German drug firm AxiCorp GmbH to expand marketing and distribution of products such as injectable insulin, generics, biosimilars and biologics in Europe
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).